#METABOLOMICS WORKBENCH xliu68_20220330_125443_mwtab.txt DATATRACK_ID:3145 STUDY_ID:ST002119 ANALYSIS_ID:AN003469 PROJECT_ID:PR001344
VERSION             	1
CREATED_ON             	March 31, 2022, 8:01 am
#PROJECT
PR:PROJECT_TITLE                 	MNK2 deficiency potentiates beta-cell regeneration via hypertranslation
PR:PROJECT_SUMMARY               	Regenerating pancreatic beta-cells is a potential curative approach for
PR:PROJECT_SUMMARY               	diabetes. We previously identified the small molecule CID661578 as a potent
PR:PROJECT_SUMMARY               	inducer of beta-cell regeneration but its target and mechanism of action have
PR:PROJECT_SUMMARY               	remained unknown. We now screened 257 million yeast clones and determined that
PR:PROJECT_SUMMARY               	CID661578 targets MAP kinase-interacting serine/threonine kinase 2 (MNK2), an
PR:PROJECT_SUMMARY               	interaction we genetically validated in vivo. CID661578 increased beta-cell
PR:PROJECT_SUMMARY               	neogenesis from ductal cells in zebrafish, neonatal pig islet aggregates and
PR:PROJECT_SUMMARY               	human pancreatic ductal organoids. Mechanistically, we found that CID661578
PR:PROJECT_SUMMARY               	boosts protein synthesis and regeneration by blocking MNK2 from binding eIF4G in
PR:PROJECT_SUMMARY               	the translation initiation complex at the mRNA cap. Unexpectedly, this blocking
PR:PROJECT_SUMMARY               	activity augmented eIF4E-phosphorylation depending on MNK1 and bolstered the
PR:PROJECT_SUMMARY               	interaction between eIF4E and eIF4G, which is necessary for both
PR:PROJECT_SUMMARY               	hypertranslation and beta-cell regeneration. Taken together, our findings
PR:PROJECT_SUMMARY               	demonstrate a targetable role of MNK2-controlled translation in beta-cell
PR:PROJECT_SUMMARY               	regeneration, a role that warrants further investigation in diabetes.
PR:INSTITUTE                     	North Carolina State University
PR:LAST_NAME                     	Liu
PR:FIRST_NAME                    	Xiaojing
PR:ADDRESS                       	Polk Hall, RM 128
PR:EMAIL                         	xliu68@ncsu.edu
PR:PHONE                         	9195154387
#STUDY
ST:STUDY_TITLE                   	Metabolomics analysis of zebrafish response to CID661578 treatment
ST:STUDY_SUMMARY                 	zebrafish larvae were treated with DMSO or CID661578 for 24 hours prior to
ST:STUDY_SUMMARY                 	global metabolomics analysis (n=6). Metabolites were extracted from pools of 10
ST:STUDY_SUMMARY                 	zebrafish larvae at 5 dpf using a 80% methanol-based extraction method. Samples
ST:STUDY_SUMMARY                 	were dried in speed vac and stored in -80C freezer until ready for LC-MS
ST:STUDY_SUMMARY                 	analysis.
ST:INSTITUTE                     	North Carolina State University
ST:LAST_NAME                     	Liu
ST:FIRST_NAME                    	Xiaojing
ST:ADDRESS                       	Polk Hall, RM 128
ST:EMAIL                         	xliu68@ncsu.edu
ST:PHONE                         	9195154387
#SUBJECT
SU:SUBJECT_TYPE                  	Fish
SU:SUBJECT_SPECIES               	Danio rerio
SU:TAXONOMY_ID                   	7955
#SUBJECT_SAMPLE_FACTORS:         	SUBJECT(optional)[tab]SAMPLE[tab]FACTORS(NAME:VALUE pairs separated by |)[tab]Raw file names and additional sample data
SUBJECT_SAMPLE_FACTORS           	-	DMSO1	Treatment:Control	RAW_FILE_NAME=DMSO1.raw
SUBJECT_SAMPLE_FACTORS           	-	DMSO2	Treatment:Control	RAW_FILE_NAME=DMSO2.raw
SUBJECT_SAMPLE_FACTORS           	-	DMSO3	Treatment:Control	RAW_FILE_NAME=DMSO3.raw
SUBJECT_SAMPLE_FACTORS           	-	DMSO4	Treatment:Control	RAW_FILE_NAME=DMSO4.raw
SUBJECT_SAMPLE_FACTORS           	-	DMSO5	Treatment:Control	RAW_FILE_NAME=DMSO5.raw
SUBJECT_SAMPLE_FACTORS           	-	DMSO6	Treatment:Control	RAW_FILE_NAME=DMSO6.raw
SUBJECT_SAMPLE_FACTORS           	-	CID1	Treatment:CID661578	RAW_FILE_NAME=CID1.raw
SUBJECT_SAMPLE_FACTORS           	-	CID2	Treatment:CID661578	RAW_FILE_NAME=CID2.raw
SUBJECT_SAMPLE_FACTORS           	-	CID3	Treatment:CID661578	RAW_FILE_NAME=CID3.raw
SUBJECT_SAMPLE_FACTORS           	-	CID4	Treatment:CID661578	RAW_FILE_NAME=CID4.raw
SUBJECT_SAMPLE_FACTORS           	-	CID5	Treatment:CID661578	RAW_FILE_NAME=CID5.raw
SUBJECT_SAMPLE_FACTORS           	-	CID6	Treatment:CID661578	RAW_FILE_NAME=CID6.raw
SUBJECT_SAMPLE_FACTORS           	-	DMSO1_Pos	Treatment:Control	RAW_FILE_NAME=DMSO1_Pos.raw
SUBJECT_SAMPLE_FACTORS           	-	DMSO2_Pos	Treatment:Control	RAW_FILE_NAME=DMSO2_Pos.raw
SUBJECT_SAMPLE_FACTORS           	-	DMSO3_Pos	Treatment:Control	RAW_FILE_NAME=DMSO3_Pos.raw
SUBJECT_SAMPLE_FACTORS           	-	DMSO4_Pos	Treatment:Control	RAW_FILE_NAME=DMSO4_Pos.raw
SUBJECT_SAMPLE_FACTORS           	-	DMSO5_Pos	Treatment:Control	RAW_FILE_NAME=DMSO5_Pos.raw
SUBJECT_SAMPLE_FACTORS           	-	DMSO6_Pos	Treatment:Control	RAW_FILE_NAME=DMSO6_Pos.raw
SUBJECT_SAMPLE_FACTORS           	-	CID1_Pos	Treatment:CID661578	RAW_FILE_NAME=CID1_Pos.raw
SUBJECT_SAMPLE_FACTORS           	-	CID2_Pos	Treatment:CID661578	RAW_FILE_NAME=CID2_Pos.raw
SUBJECT_SAMPLE_FACTORS           	-	CID3_Pos	Treatment:CID661578	RAW_FILE_NAME=CID3_Pos.raw
SUBJECT_SAMPLE_FACTORS           	-	CID4_Pos	Treatment:CID661578	RAW_FILE_NAME=CID4_Pos.raw
SUBJECT_SAMPLE_FACTORS           	-	CID5_Pos	Treatment:CID661578	RAW_FILE_NAME=CID5_Pos.raw
SUBJECT_SAMPLE_FACTORS           	-	CID6_Pos	Treatment:CID661578	RAW_FILE_NAME=CID6_Pos.raw
SUBJECT_SAMPLE_FACTORS           	-	DMSO1_Neg	Treatment:Control	RAW_FILE_NAME=DMSO1_Neg.raw
SUBJECT_SAMPLE_FACTORS           	-	DMSO2_Neg	Treatment:Control	RAW_FILE_NAME=DMSO2_Neg.raw
SUBJECT_SAMPLE_FACTORS           	-	DMSO3_Neg	Treatment:Control	RAW_FILE_NAME=DMSO3_Neg.raw
SUBJECT_SAMPLE_FACTORS           	-	DMSO4_Neg	Treatment:Control	RAW_FILE_NAME=DMSO4_Neg.raw
SUBJECT_SAMPLE_FACTORS           	-	DMSO5_Neg	Treatment:Control	RAW_FILE_NAME=DMSO5_Neg.raw
SUBJECT_SAMPLE_FACTORS           	-	DMSO6_Neg	Treatment:Control	RAW_FILE_NAME=DMSO6_Neg.raw
SUBJECT_SAMPLE_FACTORS           	-	CID1_Neg	Treatment:CID661578	RAW_FILE_NAME=CID1_Neg.raw
SUBJECT_SAMPLE_FACTORS           	-	CID2_Neg	Treatment:CID661578	RAW_FILE_NAME=CID2_Neg.raw
SUBJECT_SAMPLE_FACTORS           	-	CID3_Neg	Treatment:CID661578	RAW_FILE_NAME=CID3_Neg.raw
SUBJECT_SAMPLE_FACTORS           	-	CID4_Neg	Treatment:CID661578	RAW_FILE_NAME=CID4_Neg.raw
SUBJECT_SAMPLE_FACTORS           	-	CID5_Neg	Treatment:CID661578	RAW_FILE_NAME=CID5_Neg.raw
SUBJECT_SAMPLE_FACTORS           	-	CID6_Neg	Treatment:CID661578	RAW_FILE_NAME=CID6_Neg.raw
#COLLECTION
CO:COLLECTION_SUMMARY            	zebrafish larvae were treated with DMSO or CID661578 for 24 hours prior to
CO:COLLECTION_SUMMARY            	global metabolomics analysis (n=6). Metabolites were extracted from pools of 10
CO:COLLECTION_SUMMARY            	zebrafish larvae at 5 dpf using a 80% methanol/water-based extraction method.
CO:COLLECTION_SUMMARY            	Detailed metabolite extraction was described previously using 80% methanol/water
CO:COLLECTION_SUMMARY            	as solvent (PMID: 24410464, PMID: 24894601, PMID: 25795660) and dry pellets were
CO:COLLECTION_SUMMARY            	stored in -80 °C freezer until ready for LC-MS analysis. Pellets were
CO:COLLECTION_SUMMARY            	reconstituted into 30 μL of sample solvent (water:methanol:acetonitrile, 2:1:1,
CO:COLLECTION_SUMMARY            	v/v), and 5 μL was injected into the LC-MS.
CO:SAMPLE_TYPE                   	new
#TREATMENT
TR:TREATMENT_SUMMARY             	Chemicals (DMSO orCID661578) were added to the E3 medium for larvae to reach
TR:TREATMENT_SUMMARY             	final concentration of 10 uM. Pools of 10 wild-type (WT) larvae at 5 dpf were
TR:TREATMENT_SUMMARY             	used for each of the 6 independent biological replicates for DMSO or CID661578
TR:TREATMENT_SUMMARY             	treatment from 4-5 dpf.
#SAMPLEPREP
SP:SAMPLEPREP_SUMMARY            	Intracellular metabolites were harvested as described previously using 80%
SP:SAMPLEPREP_SUMMARY            	methanol/water as solvent (PMID: 24410464, PMID: 24894601, PMID: 25795660) and
SP:SAMPLEPREP_SUMMARY            	dry pellets were stored in -80 °C freezer until ready for LC-MS analysis. For
SP:SAMPLEPREP_SUMMARY            	metabolite analysis, pellets were reconstituted into 30 μL of sample solvent
SP:SAMPLEPREP_SUMMARY            	(water:methanol:acetonitrile, 2:1:1, v/v), and 5 μL was injected into the
SP:SAMPLEPREP_SUMMARY            	LC-MS.
#CHROMATOGRAPHY
CH:CHROMATOGRAPHY_SUMMARY        	HILIC method is for general metabolomics analysis.
CH:CHROMATOGRAPHY_TYPE           	HILIC
CH:INSTRUMENT_NAME               	Thermo Dionex Ultimate 3000
CH:COLUMN_NAME                   	Waters Xbridge amide (100 × 2.1 mm i.d., 3.5 μm)
#ANALYSIS
AN:ANALYSIS_TYPE                 	MS
#MS
MS:INSTRUMENT_NAME               	Thermo Q Exactive Plus Orbitrap
MS:INSTRUMENT_TYPE               	Orbitrap
MS:MS_TYPE                       	ESI
MS:ION_MODE                      	POSITIVE
MS:MS_COMMENTS                   	It was operated in the full-scan mode (positive ion mode only) with the
MS:MS_COMMENTS                   	resolution set at 70 000 (at m/z 200).LC-MS data were analyzed using Sieve 2.0
MS:MS_COMMENTS                   	(Thermo Scientific), and the integrated area under metabolite peak was used to
MS:MS_COMMENTS                   	compare the relative abundance of each metabolite in different samples in the
MS:MS_COMMENTS                   	same batch.
#MS_METABOLITE_DATA
MS_METABOLITE_DATA:UNITS	ion counts
MS_METABOLITE_DATA_START
Samples	DMSO1_Pos	DMSO2_Pos	DMSO3_Pos	DMSO4_Pos	DMSO5_Pos	DMSO6_Pos	CID1_Pos	CID2_Pos	CID3_Pos	CID4_Pos	CID5_Pos	CID6_Pos
Factors	Treatment:Control	Treatment:Control	Treatment:Control	Treatment:Control	Treatment:Control	Treatment:Control	Treatment:CID661578	Treatment:CID661578	Treatment:CID661578	Treatment:CID661578	Treatment:CID661578	Treatment:CID661578
acetyl-CoA	133063.821	125855.106	79763.07	68044.05	96745.416	78967.134	88387.719	79334.541	135358.299	91848.972	96118.131	71600.565
Propanoyl-CoA	31221.399	43384.341	48726.195	13642.125	23289.864	20121.597	55769.403	50613.171	90764.583	196322.619	58947.492	42712.101
crotonoyl-CoA	0	0	0	0	0	0	0	0	0	0	0	0
isobutyryl-CoA	26807.508	40590.513	48781.239	17954.34	35660.157	50901.837	109079.532	62423.67	138773.781	91589.316	149320.842	114692.787
Isovaleryl-CoA	28256.169	48897.501	58418.079	25756.686	49561.011	52287.744	148009.854	107519.577	184149.873	204500.922	235056.744	203805.444
malonyl-CoA	5929.911	5647.824	6359.547	10227.117	12042.84	1005.96	11133.408	13926.138	8915.946	2133.798	6277.836	6003.504
(S)-3-hydroxybutanoyl-CoA	0	0	0	0	0	0	0	0	0	0	0	0
Succinyl-CoA	42573.408	55697.07	57417.471	53847.744	51236.475	48101.928	72384.771	62165.325	89462.058	138883.08	63569.85	51982.62
Hydroxymethylglutaryl-CoA	0	0	0	0	0	0	0	0	0	0	0	0
MS_METABOLITE_DATA_END
#METABOLITES
METABOLITES_START
metabolite_name	Chemical formula
acetyl-CoA	C23H38N7O17P3S
Propanoyl-CoA	C24H40N7O17P3S
crotonoyl-CoA	C25H40N7O17P3S
isobutyryl-CoA	C25H42N7O17P3S
Isovaleryl-CoA	C26H44N7O17P3S
malonyl-CoA	C24H38N7O19P3S
(S)-3-hydroxybutanoyl-CoA	C25H42N7O18P3S
Succinyl-CoA	C25H40N7O19P3S
Hydroxymethylglutaryl-CoA	C27H44N7O20P3S
METABOLITES_END
#END